For: | Garg PK, Sharma J, Jakhetiya A, Goel A, Gaur MK. Preoperative therapy in locally advanced esophageal cancer. World J Gastroenterol 2016; 22(39): 8750-8759 [PMID: 27818590 DOI: 10.3748/wjg.v22.i39.8750] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i39/8750.htm |
Number | Citing Articles |
1 |
Ulrich Ronellenfitsch, Juliane Friedrichs, Maurizio Grilli, Ralf-Dieter Hofheinz, Katrin Jensen, Meinhard Kieser, Jörg Kleeff, Christoph W. Michalski, Patrick Michl, Svenja Seide, Johannes Vey, Dirk Vordermark, Tanja Proctor. Preoperative chemoradiotherapy versus chemotherapy for adenocarcinoma of the esophagus and esophagogastric junction (AEG): systematic review with individual participant data (IPD) network meta-analysis (NMA). Cochrane Database of Systematic Reviews 2021; doi: 10.1002/14651858.CD014748
|
2 |
Piyush Kumar, Ankita Mehta. Esophageal cancer: Treatment challenges and controversies. Journal of Current Oncology 2021; 4(1): 41 doi: 10.4103/jco.jco_13_21
|
3 |
Tian Zhang, Zhoubo Guo, Xi Chen, Jie Dong, Hongjing Jiang, Peng Tang, Ping Wang, Dong Qian, Wencheng Zhang, Qingsong Pang. A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy. Radiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02116-0
|
4 |
Jihui Liu, Xiyue Yang, Xin Mao, Tingting Wang, Xuhai Zheng, Gang Feng, Tangzhi Dai, Xiaobo Du. Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1089365
|
5 |
Pierfrancesco Franco, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, Elisabetta Trino, Stefania Martini, Giuseppe Carlo Iorio, Maria Antonietta Satolli, Mario Airoldi, Renato Romagnoli, Michele Camandona, Umberto Ricardi. Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials. Medical Oncology 2017; 34(3) doi: 10.1007/s12032-017-0898-1
|
6 |
Jiali Li, Zihang Zeng, Xueping Jiang, Nannan Zhang, Yanping Gao, Yuan Luo, Wenjie Sun, Shuying Li, Jiangbo Ren, Yan Gong, Conghua Xie. Stromal microenvironment promoted infiltration in esophageal adenocarcinoma and squamous cell carcinoma: a multi-cohort gene-based analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75541-4
|
7 |
Mahesh Sultania, Durgatosh Pandey, SH Chandrasekhara, Pankaj Kumar Garg. Unfavourable Vascular Anatomy for Esophageal Reconstruction: a Case for Chemoradiation in Operable Esophageal Cancer. Journal of Gastrointestinal Cancer 2018; 49(3): 319 doi: 10.1007/s12029-016-9894-5
|
8 |
Chao Xiao, Yupeng Wang, Miao Zheng, Jian Chen, Guohe Song, Zhijie Zhou, Chongzhi Zhou, Xing Sun, Lin Zhong, Erxun Ding, Yi Zhang, Liu Yang, Gang Wu, Shifeng Xu, Hong Zhang, Xiaoliang Wang. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer. Cancer Science 2018; 109(4): 1075 doi: 10.1111/cas.13516
|
9 |
Xinfang Lv, Xue Wu, Kai Liu, Xinke Zhao, Chenliang Pan, Jing Zhao, Juan Chang, Huan Guo, Xiang Gao, Xiaodong Zhi, Chunzhen Ren, Qilin Chen, Hugang Jiang, Chunling Wang, Ying‐Dong Li. Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer. Cancer Innovation 2023; 2(5): 391 doi: 10.1002/cai2.89
|
10 |
Sun Tang, Jing Ou, Yu-Ping Wu, Rui Li, Tian-Wu Chen, Xiao-Ming Zhang. Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy. Medicine 2021; 100(27): e26557 doi: 10.1097/MD.0000000000026557
|
11 |
Xiaolan Cao, Xindi Li, Xiaoyue Wang, Jinghao Duan, Shouhui Zhu, Haiyan Zeng, Yong Yin, Shuanghu Yuan, Xudong Hu. Use CT Imaging to Predict the Short-Term Outcome of Concurrent Chemoradiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma. Dose-Response 2019; 17(4) doi: 10.1177/1559325819897175
|
12 |
Ronan J. Kelly, Jaffer A. Ajani, Jaroslaw Kuzdzal, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Mendez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H. Ko, Kynan Feeney, Michael Schenker, Piotr Kocon, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M. Cleary, Markus Moehler. Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer. New England Journal of Medicine 2021; 384(13): 1191 doi: 10.1056/NEJMoa2032125
|
13 |
Stefania Martini, Francesca Arcadipane, Paolo Strignano, Rosella Spadi, Viviana Contu, Christian Fiandra, Riccardo Ragona, Giorgia Catalano, Maria Antonietta Satolli, Michele Camandona, Renato Romagnoli, Umberto Ricardi, Pierfrancesco Franco. Volumetric modulated arc therapy (VMAT) in the treatment of esophageal cancer patients. Medical Oncology 2018; 35(12) doi: 10.1007/s12032-018-1211-7
|
14 |
Giulia Manzini, Ursula Klotz, Doris Henne-Bruns, Michael Kremer. Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials. World Journal of Gastrointestinal Oncology 2020; 12(1): 113-123 doi: 10.4251/wjgo.v12.i1.113
|
15 |
Hua Zhong, Anqi Li, Yingdong Chen, Qianwen Huang, Xingbiao Chen, Jianghe Kang, Youkuang You. Comparative analysis of automatic segmentation of esophageal cancer using 3D Res-UNet on conventional and 40-keV virtual mono-energetic CT Images: a retrospective study. PeerJ 2023; 11: e15707 doi: 10.7717/peerj.15707
|